Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.

[1]  T. Quertermous,et al.  Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells , 2010, PloS one.

[2]  Masashi Yabuki,et al.  Evaluation of the Potential for Drug-Induced Liver Injury Based on in Vitro Covalent Binding to Human Liver Proteins , 2009, Drug Metabolism and Disposition.

[3]  S. Ledoux,et al.  Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes. , 2009, Toxicology and applied pharmacology.

[4]  K. Yoshizato,et al.  In vivo modeling of human liver for pharmacological study using humanized mouse , 2009, Expert opinion on drug metabolism & toxicology.

[5]  Jehyuk Lee,et al.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells , 2009, Hepatology.

[6]  Xiaolei Yin,et al.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells , 2009, Cell Research.

[7]  Dennis van Hoof,et al.  Derivation of insulin-producing cells from human embryonic stem cells. , 2009, Stem cell research.

[8]  A. Rizzino,et al.  ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells , 2009, Molecular reproduction and development.

[9]  H. Deng,et al.  Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells , 2009, PloS one.

[10]  M. Ingelman-Sundberg,et al.  Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein. , 2009, Pharmacogenomics.

[11]  P. Moghe,et al.  Expedited growth factor-mediated specification of human embryonic stem cells toward the hepatic lineage. , 2009, Stem cell research.

[12]  S. Kimber,et al.  Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines. , 2009, Stem cell research.

[13]  Peter J H Webborn,et al.  Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. , 2009, Molecular pharmaceutics.

[14]  Alvis Brazma,et al.  Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges , 2009, TheScientificWorldJournal.

[15]  T. Matsunaga,et al.  Differentiation of monkey embryonic stem cells into hepatocytes and mRNA expression of cytochrome p450 enzymes responsible for drug metabolism: comparison of embryoid body formation conditions and matrices. , 2009, Biological & pharmaceutical bulletin.

[16]  Alejandro Soto-Gutiérrez,et al.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. , 2009, Gastroenterology.

[17]  S. Nuti,et al.  Role of intracellular calcium and S-glutathionylation in cell death induced by a mixture of isothiazolinones in HL60 cells. , 2009, Biochimica et biophysica acta.

[18]  X. Pei,et al.  Lineage restriction and differentiation of human embryonic stem cells into hepatic progenitors and zone 1 hepatocytes. , 2009, Tissue engineering. Part C, Methods.

[19]  F. Sutterwala,et al.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.

[20]  T. Reh,et al.  Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. , 2009, Cell stem cell.

[21]  M. Asashima,et al.  Directed induction of anterior and posterior primitive streak by Wnt from embryonic stem cells cultured in a chemically defined serum‐free medium , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  T. Cantz,et al.  Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? , 2008, Gut.

[23]  D. Stainier,et al.  Bmp2 signaling regulates the hepatic versus pancreatic fate decision. , 2008, Developmental cell.

[24]  Dominic P. Williams,et al.  Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science , 2008 .

[25]  M. Yarmush,et al.  Augmentation of EB‐directed hepatocyte‐specific function via collagen sandwich and SNAP , 2008, Biotechnology progress.

[26]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[27]  G. Labbe,et al.  Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies , 2008, Fundamental & clinical pharmacology.

[28]  N. Nakatsuji,et al.  Effects of extracellular matrixes and growth factors on the hepatic differentiation of human embryonic stem cells. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[29]  M. Elazar,et al.  Isolation and Transcriptional Profiling of Purified Hepatic Cells Derived from Human Embryonic Stem Cells , 2008, Stem cells.

[30]  K. Kume,et al.  Differentiation of mouse and human embryonic stem cells into hepatic lineages , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  Tommy B Andersson,et al.  Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies , 2008, Drug Metabolism and Disposition.

[32]  Katsushi Tokunaga,et al.  HLA-haplotype banking and iPS cells , 2008, Nature Biotechnology.

[33]  Valérie Fessard,et al.  Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies , 2008, Drug Metabolism and Disposition.

[34]  H. Baharvand,et al.  Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. , 2008, Differentiation; research in biological diversity.

[35]  Robert Lanza,et al.  Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells , 2008, Stem cells.

[36]  Balázs Sarkadi,et al.  The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.

[37]  K. Yoshizato,et al.  Chimeric mice with humanized liver. , 2008, Toxicology.

[38]  David C Hay,et al.  Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo , 2008, Stem cells.

[39]  E. Morgan,et al.  Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. , 2008, Free radical biology & medicine.

[40]  Jaesung Park,et al.  Homogeneous differentiation of hepatocyte‐like cells from embryonic stem cells: applications for the treatment of liver failure , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  Gordon Keller,et al.  Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development , 2008, Cell.

[42]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[43]  Chad A. Cowan,et al.  Marked differences in differentiation propensity among human embryonic stem cell lines , 2008, Nature Biotechnology.

[44]  I. Kola,et al.  The State of Innovation in Drug Development , 2008, Clinical pharmacology and therapeutics.

[45]  J. Nichols,et al.  Nanog safeguards pluripotency and mediates germline development , 2007, Nature.

[46]  Ying Meng,et al.  Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo , 2007, Stem cells.

[47]  N. Nakatsuji,et al.  Transplantation of Embryonic Stem Cell‐Derived Endodermal Cells into Mice with Induced Lethal Liver Damage , 2007, Stem cells.

[48]  Magnus Ingelman-Sundberg,et al.  Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. , 2007, Pharmacology & therapeutics.

[49]  M. Ingelman-Sundberg,et al.  Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. , 2007, Biochemical pharmacology.

[50]  S. Strom,et al.  Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. , 2007, Toxicology and applied pharmacology.

[51]  S. Strom,et al.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  R. Riley,et al.  The pivotal role of hepatocytes in drug discovery. , 2007, Chemico-biological interactions.

[53]  André Guillouzo,et al.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. , 2007, Chemico-biological interactions.

[54]  J. Itskovitz‐Eldor,et al.  Directed differentiation of human embryonic stem cells into functional hepatic cells , 2007, Hepatology.

[55]  I. Tamai,et al.  Involvement of bile salt export pump in flutamide-induced cholestatic hepatitis. , 2007, Biological & pharmaceutical bulletin.

[56]  W. Cui,et al.  Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. , 2007, Cloning and stem cells.

[57]  Noriaki Tanaka,et al.  Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines , 2007, Nature Protocols.

[58]  A. Bader,et al.  The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes. , 2007, Biomolecular engineering.

[59]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[60]  George Q. Daley,et al.  Histocompatible Embryonic Stem Cells by Parthenogenesis , 2007, Science.

[61]  Stephen Dalton,et al.  Activin A Efficiently Specifies Definitive Endoderm from Human Embryonic Stem Cells Only When Phosphatidylinositol 3‐Kinase Signaling Is Suppressed , 2007, Stem cells.

[62]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[63]  R. de Kanter,et al.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction , 2006, Expert opinion on drug metabolism & toxicology.

[64]  Gordon Keller,et al.  BMP-4 is required for hepatic specification of mouse embryonic stem cell–derived definitive endoderm , 2006, Nature Biotechnology.

[65]  N. Kobayashi,et al.  Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell–derived hepatocytes , 2006, Nature Biotechnology.

[66]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[67]  I. Sauer,et al.  Evaluation of primary human liver cells in bioreactor cultures for extracorporeal liver support on the basis of urea production. , 2006, Artificial organs.

[68]  M L Yarmush,et al.  Sodium butyrate‐treated embryonic stem cells yield hepatocyte‐like cells expressing a glycolytic phenotype , 2006, Biotechnology and bioengineering.

[69]  Vera Rogiers,et al.  Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. , 2006, Current drug metabolism.

[70]  J. Castell,et al.  Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies , 2006, Expert opinion on drug metabolism & toxicology.

[71]  N. Benvenisty,et al.  Study of hepatocyte differentiation using embryonic stem cells , 2005, Journal of cellular biochemistry.

[72]  L. Sharples,et al.  Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching , 2005, The Lancet.

[73]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.

[74]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[75]  Joseph B Lopez,et al.  Recent developments in the first detection of hepatocellular carcinoma. , 2005, The Clinical biochemist. Reviews.

[76]  K. Sasaki,et al.  Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. , 2004, Tissue engineering.

[77]  N. Kaplowitz,et al.  Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. , 2004, Gastroenterology.

[78]  K. Sasaki,et al.  Cytochemical and ultrastructural characterization of growing colonies of human embryonic stem cells , 2004, Journal of anatomy.

[79]  K. Zaret,et al.  Liver development update: new embryo models, cell lineage control, and morphogenesis. , 2004, Current opinion in genetics & development.

[80]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[81]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[82]  A. Miyajima,et al.  Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors , 2004, Journal of Cell Science.

[83]  O. Yanuka,et al.  Differentiation and isolation of hepatic-like cells from human embryonic stem cells. , 2004, Differentiation; research in biological diversity.

[84]  Dominic P. Williams,et al.  Activation of hepatic Nrf2 in vivo by acetaminophen in CD‐1 mice , 2004, Hepatology.

[85]  M. Ingelman-Sundberg,et al.  Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. , 2004, Biochemical pharmacology.

[86]  Christian Trépo,et al.  Origin and characterization of a human bipotent liver progenitor cell line. , 2004, Gastroenterology.

[87]  Gordon Keller,et al.  Development of definitive endoderm from embryonic stem cells in culture , 2004, Development.

[88]  N. J. Hewitt,et al.  Phase I and II enzyme characterization of two sources of HepG2 cell lines , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[89]  M. Yarmush,et al.  Growth factors and nonparenchymal cell conditioned media induce mitogenic responses in stable long-term adult rat hepatocyte cultures. , 2004, Experimental cell research.

[90]  Mark D. Johnson,et al.  Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes. , 2004, Biochemical pharmacology.

[91]  J. S. Sidhu,et al.  Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. , 2004, Experimental cell research.

[92]  M. Pirmohamed,et al.  Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. , 2003, British journal of clinical pharmacology.

[93]  Jian Wang,et al.  Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm. , 2003, Surgery.

[94]  Frank Stahl,et al.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[95]  William M. Lee.  Acute Liver Failure in the United States , 2003, Annals of Internal Medicine.

[96]  K. Shakesheff,et al.  Long-term culture of functional liver tissue: three-dimensional coculture of primary hepatocytes and stellate cells. , 2003, Tissue engineering.

[97]  Pratima Kundu,et al.  Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells , 2003, Cell transplantation.

[98]  C. Falany,et al.  Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[99]  K. Feingold,et al.  Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. , 2002, Biochemical and biophysical research communications.

[100]  D. Shafritz,et al.  Liver stem cells and model systems for liver repopulation. , 2002, Journal of hepatology.

[101]  Y. Nakajima,et al.  In Vitro Differentiation of Embryonic Stem Cells into Hepatocyte‐Like Cells Identified by Cellular Uptake of Indocyanine Green , 2002, Stem cells.

[102]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[103]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[104]  J. Rossant,et al.  Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.

[105]  B. Hogan,et al.  Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. , 2001, Genes & development.

[106]  E L LeCluyse,et al.  Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[107]  Naohiro Terada,et al.  Hepatic maturation in differentiating embryonic stem cells in vitro , 2001, FEBS letters.

[108]  K. Zaret,et al.  A bipotential precursor population for pancreas and liver within the embryonic endoderm. , 2001, Development.

[109]  A. Miyajima,et al.  Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways , 2001, FEBS letters.

[110]  P. Beaune,et al.  Differential sensitivity of rat hepatocyte CYP isoforms to self‐generated nitric oxide , 2001, FEBS letters.

[111]  K. Zaret,et al.  Liver specification and early morphogenesis , 2000, Mechanisms of Development.

[112]  M. Schuldiner,et al.  Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers , 1999 .

[113]  U. Kneser,et al.  Influence of pancreatic islets on growth and differentiation of hepatocytes in co-culture. , 1999, Tissue engineering.

[114]  Y. Ito,et al.  Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[115]  K. Zaret,et al.  Initiation of mammalian liver development from endoderm by fibroblast growth factors. , 1999, Science.

[116]  Yoshiaki Ito,et al.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer , 1999, The EMBO journal.

[117]  A. Rodríguez-Ariza,et al.  Rapid induction of NF-kappaB binding during liver cell isolation and culture: inhibition by L-NAME indicates a role for nitric oxide synthase. , 1999, Biochemical and biophysical research communications.

[118]  M. López-Garcı́a.  Endogenous nitric oxide is responsible for the early loss of P450 in cultured rat hepatocytes , 1998, FEBS letters.

[119]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[120]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[121]  J. R. Coleman,et al.  Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. , 1996, Genes & development.

[122]  G. Ryffel,et al.  Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes , 1996, Molecular and cellular biology.

[123]  K. Itoh,et al.  Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins , 1995, Molecular and cellular biology.

[124]  K. Kaestner,et al.  Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm. , 1993, Development.

[125]  V. Rogiers,et al.  Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics. , 1993, Toxicology.

[126]  B. Zetter,et al.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.

[127]  G. Gomori.  The periodic-acid Schiff stain. , 1952, American journal of clinical pathology.

[128]  K. Yoshinari,et al.  Simultaneous expression of plural forms of human cytochrome P450 at desired ratios in HepG2 cells: adenovirus-mediated tool for cytochrome P450 reconstitution. , 2009, Drug metabolism and pharmacokinetics.

[129]  R. Hughes,et al.  An optimised method for cryopreservation of human hepatocytes. , 2009, Methods in molecular biology.

[130]  Dominic P. Williams,et al.  Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. , 2008, Expert opinion on drug metabolism & toxicology.

[131]  M. Lawless,et al.  Endoplasmic reticulum stress--a double edged sword for Z alpha-1 antitrypsin deficiency hepatoxicity. , 2008, The international journal of biochemistry & cell biology.

[132]  Li-Xin Xiang,et al.  In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate , 2007, Journal of cellular biochemistry.

[133]  Dominic P. Williams,et al.  Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes. , 2006, American journal of physiology. Cell physiology.

[134]  Hossein Baharvand,et al.  Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. , 2006, The International journal of developmental biology.

[135]  K. Bock,et al.  The role of conjugation reactions in detoxication , 2004, Archives of Toxicology.

[136]  Munir Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital , 2004 .

[137]  X. Ponsoda,et al.  Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor. , 2001, Journal of hepatology.

[138]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[139]  D. Melton,et al.  Vertebrate endoderm development. , 1999, Annual review of cell and developmental biology.

[140]  J. Chiu,et al.  Regulation and activities of alpha-fetoprotein. , 1997, Critical reviews in eukaryotic gene expression.

[141]  M L Yarmush,et al.  Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. , 1996, Biomaterials.

[142]  J. Dich,et al.  Long-term culture of hepatocytes: ethanol oxidation and effect of ethanol on enzyme activities and albumin secretion. , 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.